PatentsGlobal
PatentVest Report Illuminates Patent Strategies Driving the Next Wave of Triple-Agonist Obesity Therapies
PatentVest’s latest report offers an in-depth examination of the evolving obesity therapeutics landscape, focusing on the competitive patent environment surrounding triple-agonist drugs like Eli Lilly’s retatrutide. The study highlights the strategic importance of intellectual property, receptor-ratio engineering, and…
Thursday, May 14, 2026